Open study of TKKT01 for Diabetic Ulcers

Open study of TKKT01 for Diabetic Ulcers - Open study of TKKT01 for Diabetic Ulcers

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035042

Enrollment

Registered

2018-11-28

Start date

2018-11-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic ulcers

Interventions

A gel prepared by TKKT01 will be administered twice a week and be kept for 8 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) =>20 years of age on the day of signing the informed consent. 2) Diabetic ulcers that have not healed with standard therapy over 4 weeks.

Exclusion criteria

Exclusion criteria: 1) Patient who has serious immune diseases/liver diseases/heart diseases/blood diseases/endocrine diseases/mental diseases etc. 2) Patient who has the following diseases - immunodeficiency/various platelet abnormalities/malignant tumor/collagen disease/various blood diseases

Design outcomes

Primary

Measure	Time frame
The rate of patients who have the =>50% wound radius reduction.	—

Countries

Japan

Contacts

Public ContactMasahiko Kawai

ROHTO pharmaceutical CO.,LTD Clinical development group Development & Planning office

kawaim@rohto.co.jp0774-71-8820

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026